Loading...
Bezafibrate improves insulin resistance evaluated using the glucose clamp technique in patients with type 2 diabetes mellitus: a small-scale clinical study
BACKGROUND: Bezafibrate is mainly used to treat hypertriglyceridemia. Studies have reported that bezafibrate also improves type 2 diabetes mellitus, but the mechanism has not been fully elucidated. We performed euglycemic hyperinsulinemic clamps (glucose clamp) and meal tolerance tests (MTT) to exam...
Na minha lista:
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4213459/ https://ncbi.nlm.nih.gov/pubmed/25360162 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1758-5996-6-113 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|